Literature DB >> 27725301

Genomic diversity and phylogenetic relationships of human papillomavirus 16 (HPV16) in Nepal.

Robert Makowsky1, Pema Lhaki2, Howard W Wiener3, Madhav P Bhatta4, Michael Cullen5, Derek C Johnson3, Rodney T Perry3, Mingma Lama2, Joseph F Boland5, Meredith Yeager5, Sarita Ghimire6, Thomas R Broker7, Sadeep Shrestha8.   

Abstract

OBJECTIVES/
BACKGROUND: Sequence variants in HPV16 confer differences in oncogenic potential; however, to date there have not been any HPV sequence studies performed in Nepal. The objective of this study was to characterize HPV16 viral genome sequences from Nepal compared to a reference sequence in order to determine their lineages. Additionally, we sought to determine if five High-grade Squamous Intraepithelial Lesion (HSIL) subjects were genetically distinct from the non-HSIL subjects.
METHODS: DNA was isolated from exfoliated cervical cells from 17 individuals in Nepal who were previously identified to be HPV16-positive. A custom HPV16 Ion Ampliseq panel of multiplexed degenerate primers was designed that generated 47 overlapping amplicons and covered 99% of the viral genome for all known HPV16 variant lineages. All sequence data were processed through a custom quality control and analysis pipeline of sequence comparisons and phylogenetic analysis.
RESULTS: There were high similarities across the genomes, with two major indels observed in the non-coding region between E5 and L2. Compared to the PAVE reference HPV16 genome, there were up to 9, 4, 38, 27, 8, 7, 52, and 32 nucleotide variants in the E6, E7, E1, E2, E4, E5, L2, and L1 genes in the Nepalese samples, respectively. Based on sequence variation, HPV16 from Nepal falls across the A, C, and D lineages in this study. We found no evidence of genetic distinctness between HSIL and non-HSIL subjects.
CONCLUSIONS: The evolutionary and pathological characteristics of the representative HPV16 genomes from Nepal seem similar to results from other parts of the world and provide the basis for further studies. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPV16 lineage; HPV16 sequence; HSIL; Nepal; Phylogenetic tree

Mesh:

Year:  2016        PMID: 27725301      PMCID: PMC5136510          DOI: 10.1016/j.meegid.2016.10.004

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  22 in total

1.  Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms.

Authors:  I Zehbe; G Voglino; H Delius; E Wilander; M Tommasino
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

2.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

Authors:  Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob Desalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

3.  HPV 16 E6 sequence variations in Indian patients with cervical neoplasia.

Authors:  Narayanan Sathish; Priya Abraham; Abraham Peedicayil; Gopalan Sridharan; George Chandy
Journal:  Cancer Lett       Date:  2005-11-08       Impact factor: 8.679

4.  High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18.

Authors:  Laura Sichero; Silvaneide Ferreira; Helen Trottier; Eliane Duarte-Franco; Alex Ferenczy; Eduardo Luis Franco; Luisa Lina Villa
Journal:  Int J Cancer       Date:  2007-04-15       Impact factor: 7.396

5.  Prevalence of human papillomavirus types and phylogenetic analysis of HPV-16 L1 variants from Southern India.

Authors:  Shama Prasada Kabekkodu; Samatha Bhat; Deeksha Pandey; Vinay Koshy Varghese; Vaibhav Shukla; Supriti Ghosh; Pralhad Kushtagi; Parvati Bhat; Puthiya Mundayat Gopinath; Kapaettu Satyamoorthy
Journal:  Asian Pac J Cancer Prev       Date:  2015

6.  HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women.

Authors:  Lisa Mirabello; Meredith Yeager; Michael Cullen; Joseph F Boland; Zigui Chen; Nicolas Wentzensen; Xijun Zhang; Kai Yu; Qi Yang; Jason Mitchell; David Roberson; Sara Bass; Yanzi Xiao; Laurie Burdett; Tina Raine-Bennett; Thomas Lorey; Philip E Castle; Robert D Burk; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2016-04-29       Impact factor: 13.506

7.  Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.

Authors:  Shailja Pande; Neeraj Jain; Bhupesh K Prusty; Suresh Bhambhani; Sanjay Gupta; Rajyashri Sharma; Swaraj Batra; Bhudev C Das
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

8.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

9.  Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions.

Authors:  Luciana Bueno Freitas; Zigui Chen; Elaine Freire Muqui; Neide Aparecida Tosato Boldrini; Angélica Espinosa Miranda; Liliana Cruz Spano; Robert D Burk
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

10.  Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.

Authors:  Derek C Johnson; Madhav P Bhatta; Jennifer S Smith; Mirjam-Colette Kempf; Thomas R Broker; Sten H Vermund; Eric Chamot; Shilu Aryal; Pema Lhaki; Sadeep Shrestha
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more
  1 in total

1.  Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity.

Authors:  Philipp Schwabl; Jalil Maiguashca Sánchez; Jaime A Costales; Sofía Ocaña-Mayorga; Maikell Segovia; Hernán J Carrasco; Carolina Hernández; Juan David Ramírez; Michael D Lewis; Mario J Grijalva; Martin S Llewellyn
Journal:  PLoS Genet       Date:  2020-12-16       Impact factor: 5.917

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.